News

  • 13 December 2018

    Lilly teams up with AC Immune for Alzheimer’s drug

    Eli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorders, including...

  • 13 December 2018

    EC approves self-administration of Novartis’ Xolair

    The European Commission (EC) has approved the prefilled syringe (PFS) of Novartis’ Xolair (omalizumab) medication for self-administration by patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU).

Go Top